INDICAID is a non-invasive, rapid point-of-care diagnostic tool that is the simplest, quickest,
and cheapest method of detecting the SARS-Cov-2 antigen in individuals. INDICAID’s portability, ease-of-use, and capability for self-collection and batch testing also make it one of the most efficient ways to screen populations en masse.
INDICAID’s advantage over its competitors is the practicality of selfcollection, the comfort of anterior nasal swab, and the functionality of batch-collection with (individual) bulk testing, up to two (2) hours after collection.
